🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The overall purpose of this research study is to find a better way to treat...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2011-10-11
Trial ID
NCT01437605
Treatments Being Tested
The purpose of this clinical trial is to evaluate the benefit of the immuno...
Status
Terminated
Location
GSK Investigational Site
Start Date
2008-12-01
Trial ID
NCT00796445
Treatments Being Tested
The goals of this study are to 1) assess the safety of recombinant MAGE-A3 ...
Status
Completed
Location
University of Virginia
Start Date
2011-06
Trial ID
NCT01425749
Treatments Being Tested
The purpose of this clinical trial was to demonstrate the benefit of the im...
Status
Terminated
Location
Faculty teaching Hospital in Plzen
Start Date
2011-08
Trial ID
NCT01435356
Treatments Being Tested
The purpose of this clinical trial is to demonstrate the benefit of the imm...
Status
Terminated
Location
GSK Investigational Site
Start Date
2007-10-04
Trial ID
NCT00480025
Treatments Being Tested
The goal of this clinical research study is to learn if high-dose interleuk...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-02-22
Trial ID
NCT01266603
Treatments Being Tested
The objective of this study is to evaluate the clinical activity of the GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-14
Trial ID
NCT00942162
Treatments Being Tested
This was an open-label, single-arm, pilot study of the recombinant MAGE-A3 ...
Status
Completed
Location
New York University School of Medicine
Start Date
2011-09
Trial ID
NCT01380145
Treatments Being Tested
This study is being done to evaluate the safety and the clinical activity o...
Status
Terminated
Location
GSK Investigational Site
Start Date
2008-09-29
Trial ID
NCT00706238
The clinical objective of this clinical trial is to examine the clinical ac...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-19
Trial ID
NCT00896480
Treatments Being Tested